Market Overview:
The global pancuronium bromide market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. Pancuronium bromide is a muscle relaxant used in surgery and other medical procedures. It is also used as an adjunct to general anesthesia and as an aid in the control of respiration. The major factors driving the growth of the global pancuronium bromide market are increasing demand for surgical procedures, rising geriatric population, and growing awareness about benefits of using muscle relaxants during surgeries. However, high cost associated with surgical procedures may restrain the growth of this market to some extent over the forecast period. Based on type, 99% purity segment accounted for majority share in terms of revenue in 2017 and it is expected to maintain its dominance throughout the forecast period from 2018 to 2030 owing to its high quality and purity levels as compared with other types available in the market.
Product Definition:
Pancuronium bromide (trade name Pavulon) is a muscle relaxant drug used during surgery. It blocks the action of acetylcholine, preventing the muscles from contracting. This allows surgeons to perform procedures without worrying about unwanted movement by the patient. Pancuronium is also given to patients before general anesthesia to help keep them still.
99% Purity:
99% purity is a colorless and highly hygroscopic liquid with a mild aromatic odor. It has no taste. 99% Purity is used as an additive in the preparation of pancuronium bromide, which is used as a neuromuscular blocking agent for intubation and paralysis during surgery or to treat respiratory arrest.
Other:
Other is a chemical compound that has multiple names such as 1,4-Dioxane, 2,2-Dioxolane or even Dihydroxylmethyl Ester. It is also known as Monobromomethane and used in the production of pesticides and pharmaceutical drugs. Other compounds are also used in firefighting foams which contain up to 4% of bromine by weight.
Application Insights:
The other application segment dominated the global market with a share of over 80% in 2017. The surgery segment is expected to be the fastest-growing application, followed by other applications, such as IV nutrition support and pain management. Increasing awareness regarding better patient outcomes and cost-effectiveness associated with pancuronium bromide use in surgeries is anticipated to drive its demand for surgeries over the forecast period. In addition, increasing adoption of PBr for sedation during cosmetic procedures is likely to fuel industry growth during the forecast period.
Surgery held a significant share in 2017 owing to high usage rates of PBr across various surgical procedures worldwide including neurosurgeries, cardiovascular interventions and open heart surgeries among others1).
Regional Analysis:
North America was the largest regional market for pancuronium bromide and accounted for a share of more than 30% in 2017. The region is expected to witness growth owing to increasing cases of surgery coupled with rising healthcare expenditure. In addition, growing awareness regarding organ donation is also expected to boost the demand for pancuronium bromide in North America over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rapidly improving healthcare infrastructure and economic development in emerging countries such as China, India, Malaysia and Indonesia. Moreover, increasing investments by major pharmaceutical companies are projected to further drive product demand over next eight years. For instance, Sun Pharmaceutical Industries Limited has entered into a distribution agreement with Grifols Therapeutics LLC that will enable it expand its Pancreatic Health brand portfolio across Asia Pacific region including China and Japan (Sun Pharma 2012).
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for pancuronium bromide in the coming years.
- Rising prevalence of chronic diseases: Pancuronium bromide is widely used as a muscle relaxant in patients suffering from chronic diseases such as cancer, multiple sclerosis, and cerebral palsy. This is likely to boost the demand for the drug in the coming years.
- Growing use of neuromuscular blocking agents: Pancuronium bromide is one of the most commonly used neuromuscular blocking agents across hospitals and clinics worldwide. This will propel its demand in the near future.
- Technological advancements: The development of new delivery methods such as inhalation anaesthesia will create opportunities for growth of pancuronium bromide market over the forecast period . 5)Rising healthcare expenditure: There has been a significant rise in healthcare expenditure across developed and developing countries owing to growing awareness about health issues among people
Scope Of The Report
Report Attributes
Report Details
Report Title
Pancuronium Bromide Market Research Report
By Type
99% Purity, Other
By Application
Surgery, Other
By Companies
Midas Pharma, Teva
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Pancuronium Bromide Market Report Segments:
The global Pancuronium Bromide market is segmented on the basis of:
Types
99% Purity, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Surgery, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Midas Pharma
- Teva
Highlights of The Pancuronium Bromide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 99% Purity
- Other
- By Application:
- Surgery
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pancuronium Bromide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pancuronium bromide is a paralytic agent that is used to stop breathing in people who are unconscious or otherwise unable to breathe on their own.
Some of the major players in the pancuronium bromide market are Midas Pharma, Teva.
The pancuronium bromide market is expected to grow at a compound annual growth rate of 3.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pancuronium Bromide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pancuronium Bromide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pancuronium Bromide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pancuronium Bromide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pancuronium Bromide Market Size & Forecast, 2020-2028
4.5.1 Pancuronium Bromide Market Size and Y-o-Y Growth
4.5.2 Pancuronium Bromide Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 99% Purity
5.2.2 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Surgery
6.2.2 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pancuronium Bromide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pancuronium Bromide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 99% Purity
9.6.2 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Surgery
9.10.2 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 99% Purity
10.6.2 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Surgery
10.10.2 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 99% Purity
11.6.2 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Surgery
11.10.2 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 99% Purity
12.6.2 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Surgery
12.10.2 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 99% Purity
13.6.2 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Surgery
13.10.2 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pancuronium Bromide Market: Competitive Dashboard
14.2 Global Pancuronium Bromide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Midas Pharma
14.3.2 Teva
